<DOC>
	<DOCNO>NCT00981526</DOCNO>
	<brief_summary>This 12-week , randomize , double-blinded , placebo-controlled trial telmisartan 80 mg/day adjunctive clozapine olanzapine therapy , 70 schizophrenia subject examine telmisartan 's effect glucose metabolism , weight , food intake , rest energy expenditure , body composition . In addition , study examine insulin 's effect psychopathology cognition . Potential subject identify clinician Freedom Trail Clinic , Massachusetts General Hospital . Approximately 70 subject enrol .</brief_summary>
	<brief_title>Telmisartan Adjunctive Treatment Metabolic Problems Patients With Schizophrenia</brief_title>
	<detailed_description>The specific aim include : Primary Aims : 1 . Examine efficacy telmisartan add regular dos clozapine olanzapine improve insulin resistance . 2 . Examine efficacy telmisartan reduce fast triglyceride . Secondary Aims : 1 . Examine effect telmisartan negative symptom , positive symptom , cognitive function . 2 . Examine efficacy telmisartan improve glucose metabolism measure glucose effectiveness ( SG ) acute insulin response glucose ( AIRG ) . 3 . Examine telmisartan 's effect lipid , body composition , waist circumference , waist/hip ratio . 4 . Examine telmisartan 's effect weight , food intake rest energy expenditure . 5 . Characterize relationship change CRP , IL-6 , change fast insulin glucose , SI , SG , AIRG FSIVGTT . 6 . Characterize relationship change fast insulin glucose , SI , SG , AIRG FSIVGTT , CRP , IL-6 , change negative symptom , positive symptom cognitive function . 7 . Examine telmisartan 's effect inflammatory biomarkers include C-reactive protein ( CRP ) interleukin 6 ( IL-6 ) .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>1 . Age 1865 year 2 . Diagnosis schizophrenia , subtype schizoaffective disorder , subtype 3 . Treatment clozapine olanzapine least 6 month 4 . Stable dose antipsychotic agent least one month 5 . Well establish compliance outpatient medication 6 . Females subject eligible participate study nonchildbearing potential childbearing potential willing practice appropriate birth control method ( complete abstinence sexual intercourse , female sterilization , sterilization male partner , implant levonorgestrel , injectable progestogen , oral contraceptive , intrauterine device , double barrier method contraception use spermicide either condom diaphragm ) study . 1 . Inability provide inform consent 2 . Current substance abuse 3 . Psychiatrically unstable 4 . Significant medical illness include severe cardiovascular , hepatic , renal disease 5 . Current insulin treatment diabetes 6 . History immunosuppression 7 . Current recent radiation chemotherapy treatment cancer 8 . Chronic use steroid 9 . Pregnancy breast feed 10 . Use diuretic , digoxin , warfarin possible drugdrug interaction telmisartan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Cognition</keyword>
	<keyword>Metabolism</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Psychopathology</keyword>
</DOC>